Platelet adhesion t o the vessel wall is initiated by transport of blood platelets from the bulk flow t o the wall. The process of diffusion and convection of the platelets is affected by rheological conditions such as wall shear rate, red blood cell (RBC) deformability, and viscosity of the medium. To study the effect of plasma viscosity on platelet adhesion, perfusion experiments with a rectangular perfusion chamber were performed. Reconstituted blood, consisting of washed platelets and washed RBCs, was circulated through this chamber for 5 minutes at a wall shear rate of 300 s-'. Different LATELET ADHESION to the vessel wall is depen-P dent on transport of blood platelets to the wall.
but increased with medium viscosity above this value. Instead of human albumin solution, different plasma viscosities were obtained by dilution of Waldenstriim plasma with buffer. Plasma was depleted of fibronectin, which gave a final plasma viscdsity of 2.0 mPa . s, and was dialyzed against HEPES buffer and subsequently diluted with the dialysis buffer in different fractions (0.89 t o 2.00 mPa . s). Perfusions were performed over a purified von Willebrand factor coating on glass, or over an endothelial cell matrix, preincubated with von Willebrand factor. With both surfaces, platelet LATELET ADHESION to the vessel wall is depen-P dent on transport of blood platelets to the wall.
Various rheological factors that are of importance for the platelet transport have been
Transport of platelets in the flow is regulated by the processes of diffusion and con~ection.~ Convection refers to the movement of particles in conformity with the movement of the medium in which the particles are placed. In convection, the particles follow the streamlines of the fluid. In diffusion, the movement of particles is relative to the motion of the fluid, and motion of an entity in a stationary or smoothly flowing fluid is random when viewed particle by particle, but the net result of the random movements results in movement of particles from regions of high particle concentration to regions of low particle concentration.
The mass transport in blood can be described by the convective diffusion t h e~r y .~,~ Platelet diffusivity was found to be dependent on wall shear rate, due to shear induced red blood cell (RBC) motion.2,6 A power law was assumed between this diffusion resistance and wall shear Rotation of larger particles (RBCs) could enhance diffusivity of molecules and smaller particles (blood platelets) in the surrounding area.lOJ1 This effect is also dependent on the rigidity of the larger particles, as the mixing effect that is responsible for the increase in diffusivity will be smaller in case of more deformable particles, since the so-called swept-out volume12 will be smaller. Calculation of the brownian diffusion coefficient shows a small contribution of this mechanism to the total platelet transport. Convective diffusion due to fluid shear stresses and rotation of particles (RBCs) is the main contributor. Gravitational effects will be negligible compared with this convective diffusion. From polymer dynamics, we know that large particles move through polymer solutions more rapidly than expected from adhesion was dependent on the plasma viscosity in a similar way: at low plasma viscosities, adhesion was decreased with increasing plasma viscosity, while at higher plasma viscosities, adhesion increased with plasma viscosity. Adhesion values at higher plasma viscosity or at higher human albumin concentrations could be explained by effects of the medium on the rigidity of the RBCs, since platelet adhesion is known to be increased by enhanced RBC rigidity. Effects of the medium on the deformability of the RBCs were measured separately with the laser diffraction method. These experiments confirmed that presence of human albumin or plasma in the measuring suspension increased the rigidity of RBCs. To prevent influence of the medium on the RBCs in perfusion experiments, the RBCs were fixated with glutaraldehyde. Perfusion experiments with fixated RBCs in plasma over a von Willebrand factor preincubated endothelial cell matrix, showed a consequent decrease in adhesion with increasing plasma viscosity, according t o the diffusion theories, whereas the increase of adhesion at high plasma viscosities was lacking. This suggests that the latter effect was entirely due t o increased transport of platelets by more rigid RBCs.
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the Stokes-Einsteinian beha~i0ur.l~ This could be ascribed to the fact that the medium is not a continuum.
All theories on platelet transport show that platelet diffusivity is strongly dependent on the shear rates of the flow. Therefore, two limiting cases for platelet adherence to the wall can be distinguished6: a diffusion-controlled platelet adherence when the wall shear rate is very low (<300 s-l), and a reaction-controlled adherence when high shear rates are present (> 1,300 s-l), with the area between 300 and 1,300 s-l as intermediate.
In this report, the effect of the plasma viscosity on platelet adhesion is studied. Convective diffusion theories predict that adhesion decreases with increasing medium viscosity. We found such a decrease up to values of 0.95 mPa . s, but higher viscosities caused increased adhesion.
Studies on RBCs showed an increased rigidity under these conditions. Previous studies have shown increased platelet adhesion with more rigid RBCs. It is likely that the paradoxical effect of increased plasma viscosity is due to this phenomenon.
For personal use only. on August 30, 2017. by guest www.bloodjournal.org From
MATERIALS AND METHODS
Preparation ofperfusate. Whole blood was collected into 0.1 vol of 110 mmol/L citrate. RBCs and platelets were separated by centrifugation (45% for 10 minutes at 20°C). RBCs were washed three times with saline (150 mmol/L NaCI, 5 mmol/L aD-glUCOSe) and centrifuged (2,OOOg for 5 minutes at 20°C). Platelets were aspirin-treated and washed with Krebs-Ringer buffer as previously described.14 Platelets and RBCs were suspended in either human albumin solutions (HAS) or plasma. Human albumin (Sigma Chemical, St Louis, MO) was dissolved in Krebs-Ringer buffer (4 mmol/L KCL, 2 mmol/L NazS04, 107 mmol/L NaCI, 20 mmol/L NaHC03,19 mmol/L sodium citrate, 2.5 mmol/L CaC12,5 mmol/L aD-glUCOSe, pH 7.35) in a concentration of 160 g/L, and dialyzed overnight against this buffer. Dilution of the HAS was prevented by a tightly fitted dialysis bag. To obtain different albumin concentrations, the 16% HAS was diluted with the dialysis buffer to concentrations of OS%, 1%, 2%, 4%, and 8% HAS.
Plasma from a patient suffering from Waldenstrom disease15 (with a plasma viscosity of 2.5 mPa.s, 27 g/L IgM-K) was fibronectin-depleted by affinity chromatography on gelatinSepharose as previously described.16J7 Column fractions were screened and selected by viscosity measurements, and the final viscosity of the used fraction pool was 2.0 mPa . s. Different plasma viscosities were obtained by dilution of the plasma with HEPES buffer (150 mmol/L NaCI, 10 mmol/L HEPES, 11 mmol/L sodium citrate, pH 7.35). Plasma was first dialyzed, in a tightly fitted dialysis bag, against this buffer, and afterwards diluted to different concentrations (6.25%, 12.5%, 25%, and 50% plasma).
Platelets were resuspended in plasma or HAS at a final platelet concentration in the medium of 190 x 103/p,L. RBCs were added to avolume fraction of 40% of totalvolume of the perfusate (15 mL total volume), 5 minutes before perfusion.
RBCs were fixated by incubating equal volumes of washed RBCs and a 1% glutaraldehyde solution in saline for 1 hour at room temperature. After fixation, the cells were washed three times in saline to remove free glutaraldehyde. Since the viscosity of concentrated fixed cells is too high to pipette the packed cells, these cells were first resuspended in the plasma, and platelets were added to the perfusate 5 minutes before perfusion.
Cell matrices on glass coverslips were obtained from human umbilical vein endothelial cells as previously described.18 Coating of the matrix with von Willebrand factor was performed by incubation of the matrix with purified von Willebrand factor19 (10 p,g/mL in phosphate-buffered saline [PBS] being the average plasma von Willebrand factor Concentration) for 1 hour at room temperature. After coating with von Willebrand factor, coverslips were kept in PBS (pH 7.4) until perfusion on the same day. From previous we know that von Willebrand factor is not removed by PBS or shear stresses after coating.
Coating of coverslips. Glass coverslips were cleaned overnight by a chromium trioxide solution, and rinsed with distilled water before coating. Coating was performed by incubating a coverslip with 10 p,g/mL purified von Willebrand f a c t~r '~,~ in PBS (pH 7.4) for 1 hour at room temperature, followed by a 1-hour incubation with 4% human albumin solution to block further proteitl binding to the glass. The von Willebrand factor concentration on glass was approximately 50 ng/cm2 by this method.20 After coating, coverslips were kept in PBS until perfusion.
The perfusion system with a flat chamber as developed by Sakariassen et aI2l was used for all perfusion experiments. Before perfusion, the perfusate was prewarmed for 5 minutes at 37T, and this temperate was held constant during perfusion. After perfusion, the coverslips were washed with HEPES Endothelial cell matrix.
Perfusion procedure.
buffer (150 mmol/L NaCI, 10 mmol/L HEPES, pH 7.35) and fixated by 0.5% glutaraldehyde in PBS.
Evaluation of the platelet coverage was done by staining the coverslips (May-Griinwald/Giemsa) and determining the average surface coverage by means of light microscopy with the aid of an image ana1y~er.I~ Viscosities of the plasma dilutions atid the human albumin solutions were determined in a Contraves Low Shear 30 viscosimeter (Contraves AG, Zurich, Switzerland) at 37°C as described by Merri11.22 Viscosity was measured at different shear rates (6.0 to 128.5 s-l) to enhance accuracy of the final (newtonian) viscosity value.
RBC deformability was determined by the laser diffraction t e c h n i q~e .~~-~ A system constructed around a Contraves Low Shear 30 viscosimeter was in which shear rates could be varied between 0.56 and 410.5 s-l. Human albumin was dissolved in Krebs-Ringer buffer (290 mOsm/L, pH 7.4) at a concentration of 160 g/L, and dialyzed against this buffer. After dialysis, polyvinyl-pyrrolidone (PVP) was dissolved in the HAS and in the dialysis buffer in a concentration of 70 g/L. Mixtures of the albumin solutions and Krebs-Ringer buffer (both with 7% PVP) were made, resulting in PVP medium with human albumin concentrations of 0.5%, 1%, 2%, 4%, 8%, and 16%. The fibronectin-free plasma from the Waldenstrom patient was dialyzed against HEPES buffer (290 mOsm/L, pH 7.4). After dialysis, PVP was dissolved in the plasma and in the dialysis buffer in a concentration of 70 g/L. These plasma/PVP and buffer/PVP solutions were mixed in different plasma/buffer mixtures with loo%, 50%, 25%, 12.5%, and 6.25% plasma (vol/vol).
The differences in viscosity caused by the various plasma or albumin concentrations are negligible in comparison to the high viscosity of the PVP (60 mPa . s). Measurement samples were 5 KL washed RBCs suspended in 2.25 mL of these different media. During measurement, temperature was held constant at 37°C. Deformation was expressed as the elohgation index5 of the diffraction pattern of the cells as a function of the shear stress: E = (a -b)/(a + b), where E is the elongation index, a is the length of long axis of the diffraction pattern, and b is the length of short axis of the diffraction pattern.
Vucosity and cell deformability measurements.
RESULTS
Reconstituted blood consisting of a human albumin solution with added RBCs and platelets was circulated over an endothelial cell matrix. A human albumin solution of 160 g/L in Krebs-Ringer buffer was dialyzed against this buffer, and diluted with the dialysis buffer to different concentrations (OS%, 1%, 2%, and 4% human albumin). The viscosities of the human albumin solutions were between 0.89 and 1.85 mPa . s (Fig 1A) .
Perfusions were performed for 5 minutes at a wall shear rate of 300 s-l, in order to approximate a diffusion controlled platelet adhesion process6 (Fig 1B) . Platelet coverage decreased with increasing HAS concentration at the lower medium viscosities; at a HAS viscosity of 0. 
Adhesion studies.
For Similar results might be obtained when albumin would be a cofactor for platelet adhesion. To exclude the possibility that albumin has a direct effect on platelet adhesion, we performed perfusion experiments for 5 minutes at a higher wall shear rate of 1,800 s-l, conditions at which platelet adhesion is reaction-controlled. No significant effect due to a change in human albumin concentration on platelet adhesion was observed at this shear rate (Fig 2) , indicating that albumin has no direct effect on the adhesive process.
When plasma instead of HAS was used for the perfusion experiments, the adhesive proteins in the plasma, which are also diluted by dilution of the plasma, had to be excluded as determining factors of the adhesive process. The main adhesive proteins in the plasma are von Willebrand factor17,27-29 and f i b r o n e~t i n . 2~,~~,~~ Plasma can be easily depleted of fibronectin by affinity chromatography." To obtain a wide range of different plasma viscosities, plasma of a patient with Waldenstrom's disease (having a high plasma viscosity of 2.5 mPa . s) was made fibronectin-free by this method. After pooling the column fractions, the final plasma viscosity was 2.0 mPa . s. The plasma was dialyzed against HEPES buffer, and was diluted 1:l with the dialysis buffer. By subsequent dilutions of 1:l with the buffer, a plasma viscosity range was obtained (0.89, 0.90, 0.92, 0.95, 1.04, 1.28, and 2.00 mPa. s) (Fig 3A) . To eliminate the contribution of the von Willebrand factor in the plasma, glass coverslips, coated with 10 p,g/mL purified von Willebrand factor for 1 hour, were used as adhesive surface.20 To block any further binding of adhesive proteins from the plasma to this surface, the coverslips were subsequently coated with a 4% human albumin solution for 1 hour.
Perfusion studies with the fibronectin-depleted plasma over the purified von Willebrand factor surface at a shear rate of 300 s-l for 5 minutes (Fig 3B) showed a similar behavior as in the previous experiments. Platelet adhesion decreased when plasma viscosity was enhanced up to a plasma viscosity of 0.95 mPa . s, resulting in an adhesion value at this plasma viscosity of approximately 50% of the adhesion at a plasma viscosity of 0.89 mPa . s. At higher plasma viscosities ( > 0.95 mPa . s), adhesion values increased with plasma viscosity up to an adhesion of 160% of the minimum adhesion value at the highest plasma viscosity (2.00 mPa . s). shown to be independent of plasma von Willebrand factor.28 A possible effect of differences in plasma von Willebrand factor was further minimized by incubating the endothelial cell matrix with 10 pg/mL (corresponding to the mean plasma concentration) of von Willebrand factor. By using this preincubated endothelial cell matrix in combination with the fibronectin-free plasma (Fig 4) , a similar adhesion dependence on plasma viscosity was found as previously. At lower plasma viscosities, platelet coverage decreased with increasing plasma viscosity. At a plasma We suspected that the increased adhesion at higher medium viscosities was due to increased rigidity of the RBCs. Effects of plasma proteins on RBC rigidity were therefore studied.
Endothelial cell matrix as adhesive surface has been
Deformability of the RBCs was determined by laser diffra~tometry.23-~ The effect of the presence of human albumin or plasma on RBC rigidity was studied using suspending medium in which human albumin or plasma was present in corresponding concentrations as in the perfusion studies.
Deformation of the cells was expressed as the elongation index of the diffraction pattern at different shear stresses. The presence of human albumin in the suspending medium decreased the deformability of the cells, since the elongation index was smaller at the same shear stress in presence of plasma (Fig SA) . The presence of plasma also decreased the deformability, to an even greater degree than the presence of human albumin (Fig SB) . experiments were eliminated by fixation of the cells. The RBCs were washed three times in saline and fixated in 0.5% glutaraldehyde for 1 hour. After fixation, the cells were pended in the fibronectin-free plasma, and perfusions were performed over an endothelial cell matrix that was preincubated with von Willebrand factor. Perfusions were perPlasma viscosity [mPa.sl For 50% (--) , 25% (---), 12.5% (---), and 6.25% (-) .
formed at a wall shear rate of 300 s-l for 5 minutes (Fig 6) . Platelet adhesion now decreased with increasing plasma viscosity over the whole range of plasma viscosities. At the highest plasma viscosity of 2.00 mPa . s, platelet adhesion was approximately 50% of the maximum value at the lowest plasma viscosity of 0.89 mPa . s.
DISCUSSION
According to the convective diffusion theory, platelet adhesion was expected to decrease when medium viscosity is increased. From the results reported here, the effects of medium viscosity are more complex; at higher plasma viscosities, platelet adhesion increased with an increasing viscosity of human albumin solution or plasma.
Experiments were performed in which blood platelets and RBCs were resuspended in HAS and perfused over an endothelial cell matrix (Fig 1B) . The use of various albumin concentrations (and so various medium viscosities) showed that platelet adhesion decreased with increasing HAS viscosity at low medium viscosities, but increased at higher medium viscosities. Minimum adhesion was found at a HAS viscosity of 0.95 mPa s. Since human albumin does not contribute to the adhesive process of the platelets (Fig 2) , the observations were due purely to differences in medium viscosity.
When plasma dilutions were used as suspending medium for the platelets and RBCs, contribution of adhesive proteins in plasma to platelet adhesion had to be excluded. Since von Willebrand f a~t o r~~,~~-~~ and f i b r o n e~t i n~v~~-~~ are the two main factors in plasma involved in platelet adhesion, these factors had to be accounted for. This was done by depletion of fibronectin from the plasma, and by perfusing over a purified von Willebrand factor surface.20 Since this surface was coated afterwards with human albumin, no adhesive proteins from the plasma could adhere to this surface. Results were similar to those found in previous experiments (Fig 2) . Also in this case, the typical changes in platelet adhesion could only be due to changes in plasma viscosity.
Preincubation of an endothelial cell matrix with purified von Willebrand factor prevented the von Willebrand in the plasma from adhering to the surface (Fig 4) . Incubation concentration of the von Willebrand factor was 10 kg/mL, since this is the average plasma concentration. From other s t~d i e s ,~~J~,~~ we know that platelet adhesion is mainly dependent on von Willebrand factor at high wall shear rates (>SO0 s-l), Using this system, adhesion values again showed a decrease at increasing plasma viscosity for low For personal use only. on August 30, 2017. by guest www.bloodjournal.org From medium viscosities, and an increase in adhesion at higher plasma viscosities.
With all three methods of perfusion, comparable adhesion dependencies on the medium viscosity were thus found. The increase in adhesion with medium viscosity at higher medium viscosities could be explained by an effect of the medium on RBC rigidity.
To study the effect of presence of plasma proteins on RBC deformability separately, deformability measurements were performed. From the measurements represented in Fig 5A, it was seen that presence of human albumin in the suspending medium decreased the deformability of the RBCs. Similar experiments with plasma showed also a decrease of the deformability of the RBCs in presence of plasma (Fig 5B) . A more detailed study on the effects of plasma proteins on the deformability of RBCs will be reported separately.26 To exclude influence of the medium on the RBCs in perfusion studies, RBCs were fixated with glutaraldehyde (Fig 6) . From these experiments, it seemed clear that in the previous experiments using untreated RBCs, effects of the medium on the RBCs were responsible for the results. Adhesion experiments with these fixated cells showed a predicted behavior according to the diffusion theories, where increased medium viscosity gives rise to a decreased platelet transport.
Experimental in vitro increase of RBC rigidity causes decrease in adhesi0n.I Since increased RBC rigidity increases platelet adhesion, the deformability measurements could explain the results of the adhesion experiments at different medium viscosities. Decrease of platelet diffusion by an increase in medium viscosity, and increase of diffusion by an increase in RBC rigidity, were simultaneously present in our experiments. At low medium viscosity, effects of the increase in cell rigidity were not yet significantly active. At high medium viscosity, rigidity of the cells is that high that the increase in adhesion by an increase in rigidity is higher than the decrease in adhesion by an increased medium viscosity.
When considering plasma viscosities in the physiological range (> 1.2 mPa . s), an increase of platelet adhesion with increasing plasma viscosity is found. Since several patient groups have an increased plasma viscosity (eg, diabetes mellitus and intermittent claudication), RBC rigidity in native plasma will be increased in these patients, and therefore an increased platelet adhesion will occur. This could probably contribute to the thrombotic tendency of these patient groups. These data are obviously of major importance for the understanding of the hyperviscosity syndrome observed in Waldenstroms macroglobulinemia. The hyperviscosity is clearly caused not only by the increase in plasma viscosity, but also by a change in RBC rigidity. These consequences will be more fully discussed elsewhere.26 The present study indicates that hyperviscosity may be associated with an increased tendency to thrombosis due to increased platelet adhesion. The current data may also be of importance in patients with a nephrotic syndrome in whom plasma viscosity in total is not increased, but in whom the changed plasma protein composition affects RBC rigidity.
